查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1826986

2025年呼吸道融合细胞病毒（RSV）诊断全球市场报告

Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，呼吸道融合细胞病毒(RSV) 诊断市场快速扩张，市场规模从 2024 年的 10.1 亿美元成长至 2025 年的 11.2 亿美元，复合年增长率为 10.7%。预测期内的增长归因于照护现场诊断的普及、政府改进 RSV 诊断的倡议、儿童呼吸道疾病患病率的上升、医院内感染数量的增加以及对非侵入性诊断方法的需求不断增长。

呼吸道融合细胞病毒(RSV) 诊断市场预计将在未来几年内快速成长，到 2029 年将达到 16.7 亿美元，复合年增长率为 10.5%。预测期内成长的主要驱动因素包括：RSV感染疾病的上升、RSV 诊断意识的增强、医疗保健基础设施的扩张、全球医疗保健支出的增加以及老年人口的增长。预测期内的主要趋势包括：呼吸道融合细胞病毒诊断技术的进步、诊断设备的技术进步、快速诊断检测 (RDT) 的普及、企业诊断检测产品组合的扩展以及基因和蛋白质组学诊断技术的进步。

呼吸道融合细胞病毒(RSV) 诊断包括检测患者呼吸道合胞病毒 (RSV) 的检测和方法，通常使用呼吸道样本，例如鼻拭子或咽拭子。这些诊断对于识别导致婴儿、幼儿和老年人呼吸道疾病的 RSV 感染至关重要，也有助于制定适当的治疗和疾病管理方案。

RSV 诊断产品的主要类型包括套件和检测试剂、仪器、试剂等。套件和检测试剂是预先包装好的套装，包含试剂、材料和用于进行特定诊断测试的说明书。 RSV 检测技术多种多样，包括分子诊断、免疫检测和快速抗原检测。样本类型包括鼻拭子、咽拭子和支气管肺泡灌洗液。这些诊断方法可用于医院、诊断实验室、居家照护机构和其他医疗保健机构。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗保健领域产生了重大影响，尤其是对基本医疗设备、诊断设备和药品的供应。医院和医疗机构正疲于应对进口手术器械、诊断影像系统以及注射器和导管等消耗品不断上涨的成本，而这些产品中的许多在国内的替代品有限。由于这些不断上涨的成本给医疗保健预算带来压力，一些医疗机构正在推迟设备升级或将增加的费用转嫁给患者。此外，原料和零件的关税扰乱了关键药品和医疗设备的生产，导致供应链延迟。作为应对措施，该行业正在采用多样化的筹资策略，尽可能扩大本地生产，并游说对关键医疗产品免关税。

本研究报告是商业研究公司（The Business Research Company）新报告系列的一部分，该系列提供呼吸道融合细胞病毒(RSV) 诊断市场统计数据，包括全球市场规模、各地区市场份额、竞争对手的呼吸道融合细胞病毒病毒 (RSV) 诊断市场份额、详细的呼吸道融合细胞病毒呼吸道融合细胞病毒(RSV) 诊断市场、市场趋势和机会，以及您在呼吸道融合细胞病毒(RSV) 行业取得成功所需的数量。本呼吸道融合细胞病毒(RSV) 诊断市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

未来五年10.5%的成长预测较先前的预测略有下降0.1%。这一下降主要归因于美国与其他国家之间关税的影响。贸易摩擦可能导致法国和韩国开发的快速呼吸道合胞病毒抗原检测套组和聚合酵素链锁反应试剂价格上涨，从而导致诊断延误和儿科传染病检查成本上升，并扰乱美国的小儿科医疗服务。互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响可能会产生更广泛的影响。

呼吸系统疾病的日益普及预计将推动对呼吸道融合细胞病毒(RSV) 诊断的需求。由于空气污染、吸烟、气候变迁、都市化和慢性病盛行率上升等因素，气喘、慢性阻塞性肺病(COPD)、肺炎和呼吸道感染疾病等呼吸道疾病变得越来越普遍。 RSV 诊断在准确及时地识别感染，实现适当的治疗、管理和预防严重併发症发挥着至关重要的作用。例如，2024 年 11 月，澳洲健康与福利研究所报告称，预计 2022 年澳洲将有 280 万人（占总人口的 11%）患有气喘。 2023 年，气喘将占总疾病负担的 2.5% 和所有呼吸系统疾病负担的 35%，2022 年将有 467 人死于气喘。因此，呼吸系统疾病的日益流行正在推动 RSV 诊断市场的成长。

呼吸道合胞病毒 (RSV) 诊断市场的主要企业正专注于创新的多病毒诊断测试，以提高效率和准确性。多病毒诊断测试能够从单一患者样本同时检测多种呼吸道病毒，例如呼吸道合胞病毒 (RSV)、流感病毒和新冠肺炎 (COVID-19)。例如，2023 年 1 月，美国临床检测公司 Sonora Quest Laboratories 推出了一种新的分子诊断测试，可从单一检体中检测新冠肺炎、RSV 和流感病毒。结合这些测试简化了流程，减少了对多个样本的需求，并实现了更快、更全面的诊断。这种方法使医疗保健提供者能够快速做出治疗决策并防止这些病毒的传播。

2023年11月，芬兰生技公司Medix Biochemica收购了ViroStat LLC，收购金额未揭露。此次收购整合了ViroStat在呼吸道合胞病毒（RSV）检测单株抗体和抗原检测套件的专业知识，扩大了Medix Biochemica的感染疾病诊断产品组合。总部位于美国的ViroStat LLC专注于开发包括RSV在内的多种感染疾病的诊断解决方案，进一步巩固了Medix Biochemica在RSV诊断市场的地位。

呼吸道融合细胞病毒(RSV) 诊断市场由提供诊断咨询、研发援助、训练和技术支援等服务的营业单位所获得的收益所构成。市场规模还包括服务提供者销售或包含在其服务产品中的相关产品的价值。呼吸道融合细胞病毒(RSV) 诊断市场还包括萤光检测套组、多重检测板、样本采集设备和自动化检测设备的销售。该市场中的产品价值是“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商）或直接向最终客户销售的产品价值。该市场中的产品价值还包括产品製造商销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球呼吸道融合细胞病毒(RSV) 诊断：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球呼吸道融合细胞病毒（RSV）诊断市场：成长率分析
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场表现：规模与成长，2019-2024 年
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场预测：规模与成长，2024-2029 年，2034 年
  • 全球呼吸道融合细胞病毒(RSV) 诊断：总目标市场 (TAM)

第六章 市场细分

  • 全球呼吸道融合细胞病毒(RSV) 诊断市场（依产品类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 套件和检测试剂
  • 装置
  • 试剂
  • 其他的
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场（依技术、效能和预测），2019-2024 年、2024-2029 年、2034 年
  • 分子诊断
  • 免疫检测
  • 快速抗原检测
  • 其他的
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场（依样本类型、表现和预测），2019-2024 年、2024-2029 年、2034 年
  • 鼻拭子
  • 咽拭子
  • 支气管肺泡灌洗
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断实验室
  • 居家照护
  • 其他的
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场：套件和检测试剂细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 快速抗原检测套件
  • 基于PCR的检测
  • 血清学检测
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场：设备细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • PCR分析仪
  • 免疫检测分析仪
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场：试剂细分、类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • PCR试剂
  • 抗体试剂
  • 酵素试剂
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场：其他细分市场、按类型、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 采样装置
  • 传输介质

第七章 区域和国家分析

  • 全球呼吸道融合细胞病毒(RSV) 诊断市场各地区、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 全球呼吸道融合细胞病毒(RSV) 诊断市场（依国家/地区划分）、绩效及预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 呼吸道融合细胞病毒（RSV）诊断市场：竞争格局
  • 呼吸道融合细胞病毒（RSV）诊断市场：公司简介
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Merck KGaA

第31章：其他领先和创新企业

  • Becton, Dickinson, and Company
  • Quest Diagnostics Incorporated
  • Hologic Inc.
  • BIOMERIEUX SA
  • QuidelOrtho Corporation
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • Acon Laboratories Inc.
  • Cepheid Inc.
  • Meridian Bioscience Inc.
  • Seegene Inc.
  • LumiraDx Ltd.
  • Sekisui Diagnostics Ltd.
  • Boditech Med Inc.
  • Trinity BIoTech plc

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年呼吸道融合细胞病毒（RSV）诊断市场：提供新机会的国家
  • 2029年呼吸道融合细胞病毒（RSV）诊断市场：细分市场带来新机会
  • 呼吸道融合细胞病毒(RSV) 诊断市场 2029 年：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r34139u

Respiratory syncytial virus (RSV) diagnostics encompass the tests and methods used to detect RSV in patients, typically through respiratory samples such as nasal or throat swabs. These diagnostics are essential for identifying RSV infections, which can cause respiratory illnesses in infants, young children, and the elderly, aiding in appropriate treatment and disease management.

The primary types of RSV diagnostic products include kits and assays, instruments, reagents, and others. Kits and assays are pre-packaged sets containing reagents, materials, and instructions for conducting specific diagnostic tests. Various technologies are used for RSV detection, including molecular diagnostics, immunoassays, and rapid antigen detection tests. Sample types include nasal swabs, throat swabs, and bronchoalveolar lavage. These diagnostics are utilized in hospitals, diagnostic laboratories, home care settings, and other healthcare environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The respiratory syncytial virus (RSV) diagnostics market research report is one of a series of new reports from The Business Research Company that provides respiratory syncytial virus (RSV) diagnostics market statistics, including respiratory syncytial virus (RSV) diagnostics industry global market size, regional shares, competitors with a respiratory syncytial virus (RSV) diagnostics market share, detailed respiratory syncytial virus (RSV) diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory syncytial virus (RSV) diagnostics industry. This respiratory syncytial virus (RSV) diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory syncytial virus (rsv) diagnostics market size has grown rapidly in recent years. It will grow from $1.01 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rising adoption of point-of-care diagnostics, government initiatives to improve RSV diagnostics, rising incidence of respiratory diseases in children, growth in hospital-acquired infections, and rising demand for non-invasive diagnostic methods.

The respiratory syncytial virus (rsv) diagnostics market size is expected to see rapid growth in the next few years. It will grow to $1.67 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to the increasing prevalence of respiratory syncytial virus (RSV) infections, rising awareness about RSV diagnostics, expanding healthcare infrastructure, increasing healthcare spending globally, and growth in the elderly population. Major trends in the forecast period include advances in molecular diagnostic technologies, technological advancements in diagnostic devices, adoption of rapid diagnostic tests (RDTs), expansion of diagnostic test portfolios by companies, and advances in genetic and proteomic diagnostics.

The forecast of 10.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. pediatric practices by inflating prices of rapid RSV antigen test kits and Polymerase Chain Reaction reagents developed in France and South Korea, resulting in delayed diagnosis and higher pediatric infectious disease testing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of respiratory diseases is expected to drive the demand for respiratory syncytial virus (RSV) diagnostics. Respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and respiratory infections, are becoming more widespread due to factors such as air pollution, smoking, climate change, urbanization, and the rising incidence of chronic conditions. RSV diagnostics play a crucial role in identifying infections accurately and in a timely manner, enabling appropriate treatment, management, and prevention of severe complications, particularly in vulnerable populations. For instance, in November 2024, the Australian Institute of Health and Welfare reported that an estimated 2.8 million people (11% of the population) in Australia were living with asthma in 2022. Asthma accounted for 2.5% of the total disease burden and 35% of the burden from all respiratory conditions in 2023, with 467 asthma-related deaths in 2022. Therefore, the rising prevalence of respiratory diseases is fueling growth in the RSV diagnostics market.

Leading companies in the RSV diagnostics market are focusing on innovative multi-virus diagnostic testing to enhance efficiency and accuracy. Multi-virus diagnostic testing enables the simultaneous detection of multiple respiratory viruses, such as RSV, influenza, and COVID-19, from a single patient sample. For example, in January 2023, Sonora Quest Laboratories, a US-based clinical laboratory testing company, introduced a new molecular diagnostic test that detects COVID-19, RSV, and influenza using a single sample. By combining these tests, the process is streamlined, reducing the need for multiple samples and enabling faster, more comprehensive diagnoses. This approach allows healthcare providers to make quicker treatment decisions and helps prevent the spread of these viruses.

In November 2023, Medix Biochemica, a Finland-based biotechnology company, acquired ViroStat LLC for an undisclosed amount. This acquisition expands Medix Biochemica's infectious disease diagnostic portfolio by integrating ViroStat's expertise in monoclonal antibodies and antigen detection kits for RSV testing. ViroStat LLC, a US-based company, specializes in developing diagnostic solutions for various infectious diseases, including RSV, further strengthening Medix Biochemica's position in the RSV diagnostics market.

Major players in the respiratory syncytial virus (RSV) diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Merck KGaA, Becton, Dickinson, and Company, Quest Diagnostics Incorporated, Hologic Inc., BIOMERIEUX SA, QuidelOrtho Corporation, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Acon Laboratories Inc., Cepheid Inc., Meridian Bioscience Inc., Seegene Inc., LumiraDx Ltd., Sekisui Diagnostics Ltd., Boditech Med Inc., Trinity Biotech plc, R-Biopharm AG, GeneTex Inc., Creative Diagnostics, Certest Biotec S.L., Clarity Diagnostics LLC, Genes 2Me LLP, Coris BioConcept S.A.

North America was the largest region in the respiratory syncytial virus (RSV) diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in respiratory syncytial virus (RSV) diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Respiratory Syncytial Virus (RSV) Diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The respiratory syncytial virus (RSV) diagnostics market consists of revenues earned by entities by providing services such as diagnostic consultation, research and development support, training and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The respiratory syncytial virus (RSV) diagnostics market also includes sales of immunofluorescence test kits, multiplex panels, sample collection devices and automated testing instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Respiratory Syncytial Virus (RSV) Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory syncytial virus (rsv) diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory syncytial virus (rsv) diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory syncytial virus (rsv) diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Kits And Assays; Instruments; Reagents; Other Product Types
  • 2) By Technology: Molecular Diagnostics; Immunoassays; Rapid Antigen Detection Tests; Other Technologies
  • 3) By Sample Type: Nasal Swabs; Throat Swabs; Bronchoalveolar Lavage
  • 4) By End User: Hospitals; Diagnostic Laboratories; Home Care Settings; Other End Users
  • Subsegments:
  • 1) By Kits And Assays: Rapid Antigen Detection Kits; PCR-based Assays; Serological Assays
  • 2) By Instruments: PCR Analyzers; Immunoassay Analyzers
  • 3) By Reagents: PCR Reagents; Antibody Reagents; Enzyme Reagents
  • 4) By Other Product Types: Sample Collection Devices; Transport Media
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Merck KGaA; Becton, Dickinson, and Company; Quest Diagnostics Incorporated; Hologic Inc.; BIOMERIEUX SA; QuidelOrtho Corporation; Bio-Rad Laboratories Inc.; DiaSorin S.p.A.; Acon Laboratories Inc.; Cepheid Inc.; Meridian Bioscience Inc.; Seegene Inc.; LumiraDx Ltd.; Sekisui Diagnostics Ltd.; Boditech Med Inc.; Trinity Biotech plc; R-Biopharm AG; GeneTex Inc.; Creative Diagnostics; Certest Biotec S.L.; Clarity Diagnostics LLC; Genes 2Me LLP; Coris BioConcept S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Respiratory Syncytial Virus (RSV) Diagnostics Market Characteristics

3. Respiratory Syncytial Virus (RSV) Diagnostics Market Trends And Strategies

4. Respiratory Syncytial Virus (RSV) Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Respiratory Syncytial Virus (RSV) Diagnostics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Respiratory Syncytial Virus (RSV) Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Growth Rate Analysis
  • 5.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Respiratory Syncytial Virus (RSV) Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Respiratory Syncytial Virus (RSV) Diagnostics Total Addressable Market (TAM)

6. Respiratory Syncytial Virus (RSV) Diagnostics Market Segmentation

  • 6.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Kits And Assays
  • Instruments
  • Reagents
  • Other Product Types
  • 6.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Diagnostics
  • Immunoassays
  • Rapid Antigen Detection Tests
  • Other Technologies
  • 6.3. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nasal Swabs
  • Throat Swabs
  • Bronchoalveolar Lavage
  • 6.4. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Other End Users
  • 6.5. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Kits And Assays, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rapid Antigen Detection Kits
  • PCR-based Assays
  • Serological Assays
  • 6.6. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Analyzers
  • Immunoassay Analyzers
  • 6.7. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • PCR Reagents
  • Antibody Reagents
  • Enzyme Reagents
  • 6.8. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sample Collection Devices
  • Transport Media

7. Respiratory Syncytial Virus (RSV) Diagnostics Market Regional And Country Analysis

  • 7.1. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Respiratory Syncytial Virus (RSV) Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 8.1. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 9.1. China Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 9.2. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 10.1. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 11.1. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 11.2. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 12.1. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 13.1. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 14.1. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 14.2. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 15.1. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 15.2. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 16.1. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 17.1. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 18.1. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 19.1. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 20.1. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 21.1. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 21.2. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 22.1. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 23.1. North America Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 23.2. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 24.1. USA Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 24.2. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 25.1. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 25.2. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 26.1. South America Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 26.2. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 27.1. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 28.1. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 28.2. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market

  • 29.1. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market Overview
  • 29.2. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Respiratory Syncytial Virus (RSV) Diagnostics Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Landscape
  • 30.2. Respiratory Syncytial Virus (RSV) Diagnostics Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Respiratory Syncytial Virus (RSV) Diagnostics Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson, and Company
  • 31.2. Quest Diagnostics Incorporated
  • 31.3. Hologic Inc.
  • 31.4. BIOMERIEUX SA
  • 31.5. QuidelOrtho Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. DiaSorin S.p.A.
  • 31.8. Acon Laboratories Inc.
  • 31.9. Cepheid Inc.
  • 31.10. Meridian Bioscience Inc.
  • 31.11. Seegene Inc.
  • 31.12. LumiraDx Ltd.
  • 31.13. Sekisui Diagnostics Ltd.
  • 31.14. Boditech Med Inc.
  • 31.15. Trinity Biotech plc

32. Global Respiratory Syncytial Virus (RSV) Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Respiratory Syncytial Virus (RSV) Diagnostics Market

34. Recent Developments In The Respiratory Syncytial Virus (RSV) Diagnostics Market

35. Respiratory Syncytial Virus (RSV) Diagnostics Market High Potential Countries, Segments and Strategies

  • 35.1 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Respiratory Syncytial Virus (RSV) Diagnostics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer